Form D · Other Health Care

Rio Grande Neurosciences, Inc.

Santa Fe, NM · CIK 0001616132

Offering snapshot reported Feb 10, 2016 · SEC filing

Reported sold
$828K
Offering amount: $969K
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 8, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 10, 2016Initial$828,412No comparison9SEC filing
Jan 6, 2016Initial$3,700,000No comparison1SEC filing
Oct 26, 2015Initial$2,000,000No comparison11SEC filing
May 5, 2015Initial$1,050,065No comparison11SEC filing
Aug 19, 2014Initial$1,348,239No comparison34SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-257210
Investors from a prior offering are agreeing to reprice their Preferred Stock and as a result, the Issuer is proposing to issue up to an aggregate of 387,632 additional shares of Preferred Stock to those original investors at $2.50 per share.

Source: Form D, filed Feb 10, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven M. Gluckstern Director, Executive
Blake Gurfein Executive
Sean Hagberg Executive
Stephen Juelsgaard Director
L. John Wilkerson Director
John L Wilkerson Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
6401 Richards Ave.
Santa Fe, NM, 87508